A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans

Daniel D. Gallaher, Cynthia M. Gallaher, Gregory J. Mahrt, Timothy P. Carr, Carolyn H. Hollingshead, Robert Hesslink, John Wise

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Objective: Both chitosan and glucomannan have demonstrated hypocholesterolemic effects. A recent study in rats indicates that the combination of the two is also a potent hypocholesterolemic agent that increases fecal fat excretion. The objective of the present study was to determine the hypocholesterolemic effect of a supplement containing equal amounts of chitosan and glucomannan on blood lipid concentrations and fecal excretion of fat, neutral sterols and bile acids. Methods: Twenty-one overweight normocholesterolemic subjects (11 males and 10 females) were fed 2.4 g/day of a supplement containing equal amounts of chitosan and glucomannan. Prior to taking the supplement (initial period) and after 28 days (final period), blood was drawn for measurement of serum lipids and a three-day fecal sample collected for determination of fat, neutral sterol and bile acid excretion. Subjects maintained their normal dietary and activity patterns during the study. Results: Caloric intake and intake of fat and dietary fiber (excluding the supplement) did not differ between the initial and final periods. Serum total, HDL and LDL cholesterol concentrations were significantly lower (p < 0.05) in the final period compared to the initial period. Serum triacylglycerol concentration did not change between periods. There was a trend towards greater fecal excretion of neutral sterols and bile acids (p = 0.13 and 0.16, respectively) in the final period. However, fecal fat excretion did not differ between periods. Conclusions: Serum cholesterol reduction by a chitosan/glucomannan supplement is likely mediated by increased fecal steroid excretion and is not linked to fat excretion.

Original languageEnglish (US)
Pages (from-to)428-433
Number of pages6
JournalJournal of the American College of Nutrition
Volume21
Issue number5
DOIs
StatePublished - Oct 2002

Fingerprint

Chitosan
chitosan
dietary fiber
excretion
Fats
Cholesterol
cholesterol
Sterols
Bile Acids and Salts
bile acids
blood serum
sterols
cholesteremic effect
Serum
triacylglycerols
blood lipids
lipids
Lipids
Dietary Fiber
Energy Intake

Keywords

  • Bile acids
  • Chitosan
  • Cholesterol
  • Fecal fat
  • Glucomannan
  • Humans

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. / Gallaher, Daniel D.; Gallaher, Cynthia M.; Mahrt, Gregory J.; Carr, Timothy P.; Hollingshead, Carolyn H.; Hesslink, Robert; Wise, John.

In: Journal of the American College of Nutrition, Vol. 21, No. 5, 10.2002, p. 428-433.

Research output: Contribution to journalArticle

Gallaher, Daniel D. ; Gallaher, Cynthia M. ; Mahrt, Gregory J. ; Carr, Timothy P. ; Hollingshead, Carolyn H. ; Hesslink, Robert ; Wise, John. / A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. In: Journal of the American College of Nutrition. 2002 ; Vol. 21, No. 5. pp. 428-433.
@article{4984563f16284ff3ab68913d781018d1,
title = "A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans",
abstract = "Objective: Both chitosan and glucomannan have demonstrated hypocholesterolemic effects. A recent study in rats indicates that the combination of the two is also a potent hypocholesterolemic agent that increases fecal fat excretion. The objective of the present study was to determine the hypocholesterolemic effect of a supplement containing equal amounts of chitosan and glucomannan on blood lipid concentrations and fecal excretion of fat, neutral sterols and bile acids. Methods: Twenty-one overweight normocholesterolemic subjects (11 males and 10 females) were fed 2.4 g/day of a supplement containing equal amounts of chitosan and glucomannan. Prior to taking the supplement (initial period) and after 28 days (final period), blood was drawn for measurement of serum lipids and a three-day fecal sample collected for determination of fat, neutral sterol and bile acid excretion. Subjects maintained their normal dietary and activity patterns during the study. Results: Caloric intake and intake of fat and dietary fiber (excluding the supplement) did not differ between the initial and final periods. Serum total, HDL and LDL cholesterol concentrations were significantly lower (p < 0.05) in the final period compared to the initial period. Serum triacylglycerol concentration did not change between periods. There was a trend towards greater fecal excretion of neutral sterols and bile acids (p = 0.13 and 0.16, respectively) in the final period. However, fecal fat excretion did not differ between periods. Conclusions: Serum cholesterol reduction by a chitosan/glucomannan supplement is likely mediated by increased fecal steroid excretion and is not linked to fat excretion.",
keywords = "Bile acids, Chitosan, Cholesterol, Fecal fat, Glucomannan, Humans",
author = "Gallaher, {Daniel D.} and Gallaher, {Cynthia M.} and Mahrt, {Gregory J.} and Carr, {Timothy P.} and Hollingshead, {Carolyn H.} and Robert Hesslink and John Wise",
year = "2002",
month = "10",
doi = "10.1080/07315724.2002.10719246",
language = "English (US)",
volume = "21",
pages = "428--433",
journal = "Journal of the American College of Nutrition",
issn = "0731-5724",
publisher = "American College Of Nutrition",
number = "5",

}

TY - JOUR

T1 - A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans

AU - Gallaher, Daniel D.

AU - Gallaher, Cynthia M.

AU - Mahrt, Gregory J.

AU - Carr, Timothy P.

AU - Hollingshead, Carolyn H.

AU - Hesslink, Robert

AU - Wise, John

PY - 2002/10

Y1 - 2002/10

N2 - Objective: Both chitosan and glucomannan have demonstrated hypocholesterolemic effects. A recent study in rats indicates that the combination of the two is also a potent hypocholesterolemic agent that increases fecal fat excretion. The objective of the present study was to determine the hypocholesterolemic effect of a supplement containing equal amounts of chitosan and glucomannan on blood lipid concentrations and fecal excretion of fat, neutral sterols and bile acids. Methods: Twenty-one overweight normocholesterolemic subjects (11 males and 10 females) were fed 2.4 g/day of a supplement containing equal amounts of chitosan and glucomannan. Prior to taking the supplement (initial period) and after 28 days (final period), blood was drawn for measurement of serum lipids and a three-day fecal sample collected for determination of fat, neutral sterol and bile acid excretion. Subjects maintained their normal dietary and activity patterns during the study. Results: Caloric intake and intake of fat and dietary fiber (excluding the supplement) did not differ between the initial and final periods. Serum total, HDL and LDL cholesterol concentrations were significantly lower (p < 0.05) in the final period compared to the initial period. Serum triacylglycerol concentration did not change between periods. There was a trend towards greater fecal excretion of neutral sterols and bile acids (p = 0.13 and 0.16, respectively) in the final period. However, fecal fat excretion did not differ between periods. Conclusions: Serum cholesterol reduction by a chitosan/glucomannan supplement is likely mediated by increased fecal steroid excretion and is not linked to fat excretion.

AB - Objective: Both chitosan and glucomannan have demonstrated hypocholesterolemic effects. A recent study in rats indicates that the combination of the two is also a potent hypocholesterolemic agent that increases fecal fat excretion. The objective of the present study was to determine the hypocholesterolemic effect of a supplement containing equal amounts of chitosan and glucomannan on blood lipid concentrations and fecal excretion of fat, neutral sterols and bile acids. Methods: Twenty-one overweight normocholesterolemic subjects (11 males and 10 females) were fed 2.4 g/day of a supplement containing equal amounts of chitosan and glucomannan. Prior to taking the supplement (initial period) and after 28 days (final period), blood was drawn for measurement of serum lipids and a three-day fecal sample collected for determination of fat, neutral sterol and bile acid excretion. Subjects maintained their normal dietary and activity patterns during the study. Results: Caloric intake and intake of fat and dietary fiber (excluding the supplement) did not differ between the initial and final periods. Serum total, HDL and LDL cholesterol concentrations were significantly lower (p < 0.05) in the final period compared to the initial period. Serum triacylglycerol concentration did not change between periods. There was a trend towards greater fecal excretion of neutral sterols and bile acids (p = 0.13 and 0.16, respectively) in the final period. However, fecal fat excretion did not differ between periods. Conclusions: Serum cholesterol reduction by a chitosan/glucomannan supplement is likely mediated by increased fecal steroid excretion and is not linked to fat excretion.

KW - Bile acids

KW - Chitosan

KW - Cholesterol

KW - Fecal fat

KW - Glucomannan

KW - Humans

UR - http://www.scopus.com/inward/record.url?scp=0036789047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036789047&partnerID=8YFLogxK

U2 - 10.1080/07315724.2002.10719246

DO - 10.1080/07315724.2002.10719246

M3 - Article

C2 - 12356785

AN - SCOPUS:0036789047

VL - 21

SP - 428

EP - 433

JO - Journal of the American College of Nutrition

JF - Journal of the American College of Nutrition

SN - 0731-5724

IS - 5

ER -